- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Rossari Biotech Limited — Board Meeting, 15-10-2025: Outcome of Board Meeting
15-10-2025 | 08:32 pm
15-10-2025 | 08:32 pm
Rossari Biotech's board reported Q2 consolidated revenue of ₹586.11 Cr and PAT of ₹36.88 Cr. Key board approvals include granting 35,000 stock options, allotting 14,400 shares from exercised options, and an additional investment of up to USD 8 million in its Saudi subsidiary for expansion.
No comments yet. Be the first to comment!